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Interactions of human, cultured kidney cells with the complement
system. When heat-killed, cultured human kidney cells were incubated
with normal human serum, complement (C) activation occurred with
moderate consumption of C4, C2, C3, and CS hemolytic activity. No
loss of Cl activity and no. or only slight, reduction in C6 activity was
detectable until high cell concentrations were reached. C4 and ('2
consumption could not be prevented by blocking the primary C
pathway through prior EGTA chelation of the serum. Both living and
heat-killed kidney cells were incubated with normal serum and exam-
med for surface-bound C components using immunofluorescent tech-
niques. Heat-killed kidney cells were strongly positive for C3, which
was distributed in a diffuse, speckled pattern over the entire cell
surface. These cells were also weakly positive for IgG and Clq
immunofluorescence, but were negative for surface albumin, CS, and
13tH. In contrast, living cell suspensions showed only occasional cells
positive for C3, IgG. or Clq and all cells were negative for albumin, C.5,
and 131H. Viability staining revealed that the few C3 positive cells in
living cell suspensions belonged to a small, nonviable subpopulation.
These data indicate that dead cells can initiate limited C activation,
which can result in binding of C3 to the cell surface.
Interactions de cellules rénales humaines cultivées avec le système du
complement. Des cellules rénales humaines cultivées tuées par Ia
chaleur ont été incuhées avec du serum humain normal, l'activation clu
complement (C) a été observée, avec une consommation modérCe
d'activité hemolytique de C4, C2, C3, et CS. Aucune perte d'activite de
Cl et aucune diminution de C6 n'ont été detectables tant que des
concentrations cellulaires élevées n'ont pas été atteintes. La consom-
mation de C4 et de C2 n'a pas été empéchée par le blocage de Ia voie
primaire au moyen de Ia chelation préalable par I'EGTA. Des cellules
vivantes et des cellules tuées par Ia chaleur ont été incubées avec du
serum normal et es composants du complement fixes a Ia surface ont
été étudiés au moyen d l'immunofluorescence. Les cellules tuées par Ia
chaleur étaient fortement positives pour le C3 qui était distribué d'une
façon diffuse sur Ia totalité de Ia surface cellulaire. Ces cellules étaient
aussi faiblement positives pour IgG et Clq mais étaient negatives pour
l'albumine, CS, et 13IH. Les suspensions de cellules vivantes, au
contraire, n'avaient que quelques cellules positives pour C3, IgG, ou
Clq et toutes Ies cellules étaient negatives pour l'albumine, CS, et l3lH.
Les colorations vitales ont montré que les quelques cellules positives
pour C3 dans les suspensions de cellules vivantes appartenaient a une
petite population non viable. Ces résultats indiquent que les cellules
mortes peuvent déclencher une activation limitée de C qui peut avcir
pour résultat Ia liaison de C3 a Ia surface cellulaire.
Recognition and removal of damaged or dead cells must be an
ongoing process in vivo, requiring a mechanism(s) versatile
enough to provide normal tissue maintenance and repair while
stilt meeting demands occurring during periods of increased
tissue destruction. The complement (C) system could provide
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one mechanism for generating the biologically reactive sub-
stances required to initiate and sustain these responses. In
addition to immunologically-initiated activation, C also be-
comes activated following nonantibody-dependent interactions
with certain particles including zymosan [I], Iipopolysaccharide
[2], and positively charged liposomes of defined composition
[3]. Several lines of evidence suggest that biological membranes
may be converted to alternative pathway activators following
viral infection or chemical or physical alteration. C3 conversion
occurs when lymphoblastoid cells infected with Epstein-Barr
virus are incubated with human serum [4j, measles-infected
HeLa cells activate a mixture of isolated alternative pathway
components [5], and non-C-activating sheep erythrocytes be-
come activators on removal or oxidation of surface sialic acid
residues [6, 7]. We have previously shown that when heat-
killed, cultured human kidney cells were incubated in normal
human serum, cell-dependent activation of C, including conver-
sion of factor B and C3, ensued [8]. Although heat-killed kidney
cells could induce C activation via the alternative C pathway,
C3 conversion was more extensive in serum supporting the
classical pathway, These data suggested that C-mediated reac-
tions may be associated with in vivo recognition and clearance
of damaged tissue. We have used the heat-killed kidney cell
model to investigate how dead cells may differ from living cells
in their reactions with the C system. Kidney-cell-bound C
components or regulatory proteins have been evaluated by
immunofluorescent techniques; in addition, we have examined
the serum source to determine individual C component con-
sumption during interaction with killed kidney cells.
Methods
Blood group AB serum was used as a source of normal
human C in these experiments. The blood was clotted (room
temperature for 30 mm; then 4°C for 2 hr), and the serum was
stored at —70°C. To block classical and alternative pathway
activity, we chelated serum to 40 mti with ethylenediamine
tetraacetjc acid (EDTA, Sigma). To block classical pathway
activity, we chelated serum to 10 mr't with ethyleneglycol-bis-
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(3-aminoethyl ether)-N,N'-tetraacetic acid (EGTA, Sigma) and
supplemented it with I mi magnesium chloride.
Cl, C4, and C2 were assayed as recommended by Cordis
Laboratories (Miami, Florida) by the method of Nelson [91
using EAC4h, EACISP, and EACIPP4hL obtained from Cordis
Laboratories. Functionally pure guinea pig C2 was obtained
from Dr. H. Gewurz (Rush Medical Center, Chicago, Illinois).
C3 hemolytic titers were determined using EAC 142 and guinea
pig serum, treated with hydrazine (Eastman, Rochester, New
York) and diluted to 1:2400, as a source of C5—9 [101. EAC43
treated with antrypol (FBA Pharmaceuticals, New York, New
York) was used with guinea pig serum, treated with hydrazine
potassium thiocyanate (Sigma) and diluted 1:200, to measure CS
hemolytic activity [101. C6 hemolytic titers were measured
using C6-deficient rabbit serum as previously described [8].
The percent of native C3 converted to its more anodally
migrating form was determined by crossed immunoelectropho-
resis [II] in agarose gel containing barbital buffer (10 mi
EDTA) at a pH of 8.6. The separated proteins were reelectro-
phoresed into agarose containing antiserum nionospecific for
human C3 (Atlantic Antibodies, Westhrook, Maine). The plates
were dried and stained with Coomassie Blue. The percentage of
C3 conversion was calculated from the area under the peaks.
Primary cultures were established from a collagenase diges-
tion of the cortical tissue of normal human kidneys, and the
cultures were maintained as described [81. Kidney cells were
removed from the culture dishes by incubation (15 mm, 37°C)
with Hanks' balanced salt solution without calcium or magne-
sium (HBSS; GIBCO, Grand Island, New York) containing 1
mM EDTA, and washed twice in 100 volumes of HBSS. A cell
and viability count (trypan blue dye exclusion) was made: then
the cells were either used directly (living cells) or after being
killed by heating for 1 hour at 56°C (heat-killed cells). Cells were
extensively washed with HBSS prior to use.
Immunofluorescent staining of the suspensions of kidney
cells were performed by standard techniques with appropriate
modifications for the demonstration of cell surface components.
Staining for human IgG, albumin, Clq, and C3 was performed
using a direct procedure. Coded cell suspensions were washed
three times in a solution of PBS-BSA (sodium phosphate, 0.05
M, pH of 7.2; sodium chloride, 0.9%; and bovine serum
albumin, 4.0%) and then incubated for 30 mm at room tempera-
ture with the fluoresceinated antibody (FITC-Ab). The fluores-
cein conjugates (Behring Diagnostics, Somerville, New Jersey)
were pretested for specificity by immunoelectrophoresis, and
adsorbed with cultured human kidney cells. The antisera were
pretested to determine the working dilutions by examining
serial dilutions for the strongest staining with the least back-
ground. Following the staining step, the cells were washed
three more times and examined with a Zeiss photomicroscope
II by incident and transmitted dark-field phase fluorescence
using combined KP 490 and BG 138 primary filters and a #50
secondary filter. Coincident staining of cells with trypan blue
and FITC-Ab was determined by examination of the cells by
incident fluorescence and white-light transmission microscopy.
Staining for I3lH and CS was performed in a similar manner
except an indirect (two-step) procedure was used. Preabsorbed
and diluted goat anti-CS or lH (Atlantic Antibodies) or normal
goat serum was used for the first staining step followed by three
Table 1. Complement activation and uptake by cultured human
kidney cells
Qualitative cell bindingdSerum
Cellsh chelation % C3 conversion° Albumin IgG Clq C3
Living None 14 6 negative
ECTA 12 8 netagive
Heat-killed None 46 8 negative + I + I +4
EGTA 38 5 negative + I + 1 +2
EDTA 0 negative + I + I
Living or heat-killed kidney cells were incubated in normal or
chelated AB serum (0.5 x IO per 50 il of serum; 37° C, I hr). The
kidney cells were removed and after washing and staining were
evaluated for surface binding of the indicated protein. C3 conversion in
the serum source was determined by crossed immunoelectrophoresis.
Viability was assessed by trypan blue; living suspensions were 70—
95% viable, dead cell suspensions were greater than 95% nonviable.
The first figure is the average of two experiments, the remaining
column figures are the mean of three experiments. Values are su.
Direct iminunofluorescence staining was graded as negative to 4+.
The symbol indicates occasional cells with positive staining.
washes and a second staining step in FITC-Ab against goat IgG.
Frozen sections of human skin and kidney biopsies were used
as positive controls for I3lH and C5 staining.
The coded cell samples were graded for staining on a scale of
negative to 4+ among the different cell suspensions of each of
three separate experiments. The various cell suspensions were
also photographed under standard exposure conditions and
ranked for intensity of staining as above.
Results
Immunofluorescent detection of Clqand C3 bound to living
or heat-killedkidney cells. Living or heat-killed kidney cells (0.5
x l0/50 1.d of serum) were incubated in AB serum, washed,
and examined for bound serum proteins using immunfluores-
cent staining techniques (Table 1). All cell preparations were
negative when examined for bound albumin, indicating little
nonspecific serum protein adsorption. Suspensions of living
cells contained only relatively few cells that were positive in
staining for IgG, Clq, or C3 (Fig. la). Because living cell
populations contained 5—30% dead cells, viability staining was
performed in conjunction with immunofluorescence. The ma-
jority of cells that were positive for C3 were also judged non-
viable, being unable to exclude trypan blue. Not all dead cells
were C3 positive. In contrast, notable differences were seen in
the immunofluorescent staining of the heat-killed kidney cells.
These cell suspensions were negative for cell bound albumin,
showed a very weak staining for LgG (Fig, lb) and Clq, and
stained intensely for surface bound C3 (Fig. Ic). C3 staining,
strongest on cells incubated in serum supporting both path-
ways, was distributed in a diffuse pattern over the entire surface
of the dead cell (Fig. I, c and d). C3 binding was abolished in
EDTA-chelated serum although the weak IgG and Clq binding
was not. Dead or living cells incubated in buffer instead of
serum never showed immunofluorescent staining.
The extent of C activation was also determined by measuring
C3 conversion in the serum after removal of the cells (Table I).
Living cells produced considerably less (0 to 20%) C3 conver-
Human kidney cell InteractIons with complement 439
Pig. L Immunq'iuourescent staining of IgG and C bound to living or heat-killed kidney cells, a Living cdli (XSlS).Onlyan occasional
cell in living suspensions stained positively forD, and these were judged nonviable by their inability to exclude trypan blue. I, to d Heat-
killed kidney cells (xSiS). Heat-killed kidney cells stained very weakly positive for lgG (panel b). Unlike living cells, dead kidney cells
Incubated in normal (panel c) or EUTA-chelated( d) ltunn serum are strongly positive for surface-bound C3. Cells incubated in
serum supporting both complement pathways, however, showmore Intense C s1"ng-
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Table 2. Effect of heat-killed kidney cells on complement hemolytic
activityo
% Decrease in hemolytic complement component
Serum
chelation Cl C4 C2 C3 C5 C6
2.7 44.7 56 30.5 34.7 7.6
ND" 33 69 25 25 23
Heat-killed kidney cells were resuspended in normal or EGTA-
chelated AB serum (0.5 x 10/50 p.!) at 00 C, immediately centrifuged
(00 C), and half the serum was removed to serve as the zero time point.
The remaining cells and serum were resuspended and incubated at
370 C for 40 mm, The serum was assayed for individual C components
and the hemolytic titers compared to the time = 0 sample.
b Mean SD of three experiments with the exception of C3, which is
the average of two experiments.
a Single experiment
"Not determined. Chelation of serum with EUTA decreases Cl titer
to less than 3% of normal, making serum-EGTA unsuitable for deter-
mining alternative pathway consumption of Cl by heat-killed kidney
cells.
sion than equal numbers of heat-killed kidney cells (33 to 55%).
EGTA chelation slightly reduced, and EDTA chelation prevent-
ed fluid-phase C3 conversion.
Lack of binding of C5 or 13/H to living or heat-killed kidney
cells. Two additional antisera, anti-C5 and anti-131H, were used
to further examine binding of C components to damaged kidney
cells. Binding of CS was examined to test for involvement of the
distal C sequence with possible assembly and binding of the CS
to C9 effector sequence to the cell surface. The binding to and
interaction of 131H with C3b plays a critical role in regulation of
the alternative C pathway [12], Although the heat-killed kidney
cells were C3-positive, no binding of C5 or 13lH was detectable
on the surfaces of either living or heat-killed kidney cells. These
antisera, however, could readily detect CS or 131H in C-
containing complexes in skin or renal biopsy sections used as
positive controls.
Consumption of C components during C activation by heat-
killed kidney cells. Incubation of heat-killed kidney cells with
normal serum leads to C3 conversion in the serum and binding
of C3 to the killed cells. Experiments were made to determine
which other C components were involved and the extent of C
consumption that occurred. Heat-killed kidney cells were incu-
bated with AB serum or EGTA-chelated AB serum, and
following removal of the cells hemolytic assays for individual C
components were made. The 50% hemolytic titers were com-
pared with the same serum exposed to, but not incubated with,
the heat-killed kidney cells (time = 0) (Table 2). At 0.5 x l0
cells per 50 p.1 of serum (the concentration used in the immuno-
fluorescent binding studies), no decrease in Cl could be detect-
ed. Moderate reductions in C4, C3, and C5 hemolytic titers
occurred, whereas a 50% loss of C2 activity was noted. The
amount of C6 loss has been variable; no decrease in hemolytic
titer occurred in three of six experiments with a maximum of
34% loss in the remaining three. The individual component
hemolytic titers continued to fall as the cell concentration was
increased (Fig. 2), Before a detectable decrease in Cl hemolytic
activity occurred, 2 x l0 cells per 50 p.l of serum were
required. Similarly C6 activity was lost relatively slowly. The
concentration-dependent decrease in C3 hemolytic titer corre-
Fig. 2. Complen,e,,t consumption profile for individual C components
fo/lowjn' i,,cubati,,n of heat—killed human kidney cells with normal
blood group AB serum. Kidney cells were used at 0.5 x l0 (open), l0
(stippled), 2 X l0 (shaded), or 4 x iO (closed bar) per 50 p.1 of serum.
lated with the increased serum C3 conversion as measured by
crossed-immunoelectrophoresis. The degree of C3 conversion
and loss of C3 hemolytic activity appeared to plateau. We have
consistently found a maximum C3 conversion will be reached
and cannot be surpassed by increasing cell concentration within
a given experiment, indicating that an earlier component such
as factor B may becoming limiting.
Discussion
Using immunofluorescent techniques, we have shown that
incubation of heat-killed kidney cells with normal AB serum
results in a strong accumulation of C3 and a weak binding of
IgG and Clq to the kidney cell surfaces. No similar binding of
C3 was detected on living kidney cells incubated under similar
conditions. Only an occasional cell in the living cell suspensions
was positive for surface-bound IgG, Clq, or C3. Neither living
nor dead cells bound detectable albumin, CS, or the alternative
pathway control protein, 131H. The disparity of C3 accumula-
tion on living or killed cells was also reflected in the amount of
C3 conversion occurring in the serum source (0 to 20 compared
with 33 to 55%). Undoubtedly, the C3 conversion obtained
using living cell populations at least partially reflected C activa-
tion initiated by the small, C3-staining subpopulation of cells,
which were judged nonviable being unable to exclude trypan
blue.
The hemolytic data showing consumption of individual C
components supports our previous finding [8] that C activation
by heat-killed kidney cells involves both pathways. Using
EGTA-chelated serum or hypogammaglobulinemic serum, we
had found that the intact classical pathway was not necessary
for, but did enhance, the C3 conversion by heat-killed kidney
cells. At the lower cell concentrations, used both in those
studies and in the immunofluorescent studies reported herein,
consumption of C4 and C2 occurred even in the absence of
demonstrable Cl consumption. Surprisingly, this loss was not
prevented by prior EGTA chelation of the serum. Because 0.01
mM EGTA-chelated serum could not support the lysis of ShEA,
it would appear that normal classical pathway activation cannot
account for the C4 and C2 consumption.
As cell concentrations were increased, the hemolytic titers of
individual components decreased. C4 and C2 appeared most
sensitive whereas Cl and C6 were least affected by increasing
cell numbers. We have previously shown that the release of
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heat-killed kidney cells does not contribute to C3 activation at
lower cell concentrations [8]. Living human kidney cells do,
however, contain soluble components that at neutral pH can
cleave C3 and reduce the hemolytic activity of the individual C
components (unpublished observations). Whether these sub-
stances persist following heat killing of the kidney cells and are
released in sufficient quantities to contribute to the decrease in
C4 and C2 hemolytic activity or the increased C consumption
seen at higher cell concentrations is to he determined. These C
consuming substances may be similar to C5-dependent, chemo-
tactic factor generating substances released from rabbit kidney
cells grown in primary culture [131.
In contrast to living cells, the majority of dead cells stained
very weakly for lgG. This staining may be attributable to
binding of natural antibodies to cryptic determinants not usually
available on an unmodified, living cells. Alternatively, this
could represent nonspecific binding of lgG to newly exposed
sites on the heat-killed kidney cells, for example, aggregated
IgG to Fc receptors. The role of lgG in these reactions is yet to
be determined.
Although alternative pathway activation can be induced by
heat-killed kidney cells, there appears to be little involvement
of distal C components. CS cannot be detected bound to the
cell, there is modest loss of CS hemolytic titer, and there is little
or no loss of C6 activity at lower cell numbers. This may be due
to failure to stabilize the alternative pathway C3 convertase on
these surfaces or be due to inefficient conversion of the C3
cleaving enzyme to a CS convertase. Similarly, Giclas, Pickard,
and Olson [141 have shown that isolated heart mitochondria
activate C, but this activation does not extent to include the
distal components. Why these biological surfaces behave differ-
ently from alternative pathway activators such as zymosan is
unknown, but suggests additional regulatory steps.
Establishment of the alternative pathway follows binding of
C3b to surfaces that favor C3b-factor B interactions over C3B-
lH interactions [15]. Binding of 31H to living or dead kidney
cells could not be demonstrated using immunofluorescent tech-
niques with antiserum that readily detected lH in C-containing
complexes of skin or renal biopsy sections. Failure to detect
3lH binding could indicate lack of 131H regulation of C3
convertase formation on kidney cell surfaces. Alternatively, the
affinity of 1H for C3b on these surfaces might be low and the
level of binding insufficient to permit fluorescence detection.
Recently, Fearon [161 has shown that human erythrocyte
membranes contain a protein that acts similarly to lH to cause
decay-dissociation of factor B. thereby regulating alternative
pathway C3 convertase formation. The presence of this type of
protein in a nucleated cell membrane and its role in restricting C
activation at a cell surface will be important to determine.
Our data indicate that some form of C3 becomes bound to the
dead cells. The loss of hemolytic activity and increase of C3
conversion products in serum suggest that C3b may be bound to
these cells. Whether the bound C3 is opsonically active or can
be converted to a biologically reactive form of C3 is yet to be
determined. C activation by dead cells is not unique to kidney
cells killed by heat treatment. C3 conversion occurs when
serum is incubated with cells killed by mechanical means,
metabolic inhibitors, or irradiation (Baker PJ, unpublished
observations). We believe these findings will be relevant to
delineating events that can initiate an inflammatory response at
an in vivo site of tissue injury.
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